Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
9/13/2024 | $6.50 | Neutral → Buy | Colliers Securities | |
9/10/2024 | $6.00 | Hold | Deutsche Bank | |
9/10/2024 | $6.00 | Buy | Guggenheim | |
9/5/2024 | Underperform | Wolfe Research | ||
8/20/2024 | Mkt Perform | Barrington Research | ||
8/19/2024 | Buy → Neutral | Seaport Research Partners | ||
7/31/2024 | $5.00 | Buy | The Benchmark Company | |
7/30/2024 | $8.00 | Neutral → Underweight | JP Morgan |
Refined the focus of the Phase 3 program to accelerate path to potential U.S. approval and commercial launch in the Company's highest priority marketDiscontinued the ex-U.S.-based PROACT 2 trial and focused Company resources on PROACT 1 to expedite enrollment and accelerate estimated topline data readout to Q3 2027 WINSTON-SALEM, N.C., Sept. 03, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (NASDAQ:PROK) ("ProKidney" or the "Company"), a late clinical-stage biotech company focused on the development of a first-in-class cell therapy candidate for chronic kidney disease (CKD), today announced strategic updates to its Phase 3 program for rilparencel, an investigational treatment to potentiall
Current Blink President & CEO Brendan Jones to Retire on January 31, 2025 Bowie, Md., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ:BLNK) ("Blink" or the "Company"), a leading global manufacturer, owner, operator and provider of electric vehicle (EV) charging equipment and services, today announced that its President & CEO, Brendan Jones, will retire on January 31, 2025 concluding 5 years of dedicated service. Following his retirement, Jones will remain involved with the Company as a board member and executive advisor through July 2025. Effective February 1, 2025, Michael (Mike) Battaglia, the Company's Chief Operating Officer (COO), will be promoted to the role of Presid
Jason McDonell Appointed CEO; Joining Company on September 9, 2024 Mike Egeck Departs Leslie's; Chairman John Strain to Serve as Interim CEO Until Mr. McDonell Joins Company Reaffirms Fiscal 2024 Outlook PHOENIX, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Leslie's, Inc. (("Leslie's" or the "Company", NASDAQ:LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry, today announced the appointment of Jason McDonell as Chief Executive Officer, effective September 9, 2024. Mr. McDonell will also join Leslie's Board of Directors at that time. John Strain, Leslie's Chairman of the Board, has been appointed Interim Chief Executive Officer, and will lead the C
4 - Leslie's, Inc. (0001821806) (Issuer)
4 - Leslie's, Inc. (0001821806) (Issuer)
4 - Leslie's, Inc. (0001821806) (Issuer)
4 - Allbirds, Inc. (0001653909) (Issuer)
3 - Allbirds, Inc. (0001653909) (Issuer)
4 - Leslie's, Inc. (0001821806) (Issuer)
For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons
For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of
For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO
144 - QuantumScape Corp (0001811414) (Subject)
144 - QuantumScape Corp (0001811414) (Subject)
8-K - PROKIDNEY CORP. (0001850270) (Filer)
Colliers Securities upgraded Medical Properties Trust from Neutral to Buy and set a new price target of $6.50
Deutsche Bank resumed coverage of QuantumScape Corporation with a rating of Hold and set a new price target of $6.00
Guggenheim initiated coverage of ProKidney Corp. with a rating of Buy and set a new price target of $6.00
U.S. stock futures were lower this morning, with the Nasdaq futures dipping around 0.5% on Thursday. Shares of Ford Motor Company (NYSE:F) fell sharply in today's pre-market trading following a second-quarter earnings miss. Ford reported second-quarter revenue of $47.8 billion, up 6% year-over-year. The revenue beat a Street consensus estimate of $44 billion according to data from Benzinga Pro. The company reported quarterly earnings per share of 47 cents, missing a Street consensus estimate of 68 cents. Ford Motor shares dipped 13% to $11.90 in the pre-market trading session. Here are some big stocks recording losses in today's pre-market trading session. Edwards Lifescience
QuantumScape Corporation (NYSE:QS) reported its second-quarter financial results Wednesday. Here's a look at the details: The Details: QuantumScape reported GAAP quarterly losses of 25 cents per share which missed the analyst consensus estimate of losses of 23 cents by 8.7%. The company reported capital expenditures in the second quarter were $18.9 million and primarily supported equipmentpurchases for low-volume QSE-5 prototype production, as well as the Cobra process and other equipment as the company prepares for higher-volume QSE-5 prototype production in 2025. QuantumScape ended the second quarter with $938 million in liquidity. The company said its recent licensing deal w
SC 13G/A - Leslie's, Inc. (0001821806) (Subject)
SC 13G/A - NOVAVAX INC (0001000694) (Subject)
SC 13G/A - Allbirds, Inc. (0001653909) (Subject)
Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now available at thousands of locations nationwideNovavax's updated vaccine is the only protein-based option available in the U.S. this fall for individuals aged 12 and olderGAITHERSBURG, Md., Sept. 13, 2024 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to prevent COVID-19 in individuals aged 12 and older are in stock at major pharmacy retailers across the U.S.
Executed New Lease Agreements with Four Quality Replacement Operators Completed Safe and Orderly Transitions of Operations at 15 Hospitals Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced that it reached a global settlement agreement with Steward Health Care System ("Steward"), its secured lenders ("the Lenders") and the Unsecured Creditors Committee ("UCC") that restores MPT's control over its real estate, severs its relationship with Steward and facilitates the immediate transition of operations to quality replacement operators at 15 hospitals around the country. Regarding the settlement, the Company issued the following statement: "From our initial u
SINGAPORE, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The HiFi Solves Sub-fertility Consortium, an innovative collaboration involving five leading centers across the Asia-Pacific region, announces work aimed at redefining the landscape of fertility research. Utilizing PacBio HiFi long-read sequencing, the consortium, led by KK Women's and Children's Hospital (KKH) in Singapore, is pioneering the use of PacBio HiFi long-read sequencing to enhance the diagnosis and treatment of subfertility and recurrent miscarriages (RPL). The HiFi Solves Sub-fertility Consortium integrates DNAstack's federated data platform, the world's first solution to enable the creation and analysis of global federated networ
Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.08 per share of common stock to be paid on October 10, 2024, to stockholders of record on September 9, 2024. About Medical Properties Trust, Inc. Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 435 facilities and approximately 42,000 licensed beds in nine countries and across three continents as of June 30,
SEATTLE, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended June 30, 2024. "Q2 was a strong quarter, benefitting from consistent revenue growth and margin expansion," said Margi Tooth, President and Chief Executive Officer of Trupanion. "We were able to once again deliver consistent subscription revenue growth while generating free cash flow of $24 million over the past 12 months. Discretionary profit from our core subscription business increased 63% in the quarter, and we look forward to gradually deploying more capital at high estimated internal rates
Achieved total revenue of $415 million in the second quarter of 2024 and ended the period with $1.1 billion in CashFiled with the U.S. FDA and EMA for authorization of updated 2024-2025 formula COVID-19 vaccineReceived $570 million in upfront payment and equity investment from Sanofi; progressed operationalization of Sanofi partnershipPhase 3 trial initiation for COVID-19-Influenza Combination and stand-alone influenza vaccines planned for Q4 2024; data expected by mid-2025Company to host conference call today at 8:30 a.m. ETGAITHERSBURG, Md., Aug. 8, 2024 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announc